๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Robert Burns

Stock Analyst at H.C. Wainwright

(4.50)
# 1,126
Out of 5,189 analysts
1108
Total ratings
36.6%
Success rate
9.8%
Average return

Stocks Rated by Robert Burns

PMV Pharmaceuticals
Nov 20, 2026
Reiterated: Buy
Price Target: $5
Current: $0.876
Upside: +470.78%
ORIC Pharmaceuticals
Nov 19, 2026
Reiterated: Buy
Price Target: $27 → $20
Current: $7.36
Upside: +171.74%
Prelude Therapeutics
Nov 18, 2026
Reiterated: Buy
Price Target: $8
Current: $3.23
Upside: +147.68%
Cullinan Therapeutics
Nov 17, 2026
Reiterated: Buy
Price Target: $35
Current: $8.89
Upside: +293.70%
TuHURA Biosciences
Nov 17, 2026
Reiterated: Buy
Price Target: $10
Current: $1.25
Upside: +700.00%
Nuvation Bio
Nov 17, 2026
Reiterated: Buy
Price Target: $21
Current: $3.80
Upside: +452.63%
Revolution Medicines
Nov 17, 2026
Reiterated: Buy
Price Target: $350
Current: $161.20
Upside: +117.12%
BlossomHill Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $35
Current: $14.51
Upside: +141.21%
Cardiff Oncology
Nov 16, 2026
Reiterated: Buy
Price Target: $9
Current: $0.8528
Upside: +955.35%
Immix Biopharma
Nov 16, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $6.96
Upside: +287.93%
Reiterated: Buy
Price Target: $245 → $220
Current: $68.97
Upside: +218.98%
Reiterated: Buy
Price Target: $73
Current: $46.53
Upside: +56.89%
Reiterated: Buy
Price Target: $40
Current: $27.44
Upside: +45.77%
Reiterated: Buy
Price Target: $42 → $36
Current: $8.44
Upside: +326.54%
Reiterated: Buy
Price Target: $11
Current: $1.31
Upside: +739.69%
Reiterated: Buy
Price Target: $27
Current: $10.52
Upside: +156.65%
Reiterated: Buy
Price Target: $130 → $110
Current: $80.96
Upside: +35.87%
Reiterated: Buy
Price Target: $23 → $21
Current: $1.45
Upside: +1,348.28%
Reiterated: Buy
Price Target: $68 → $67
Current: $21.73
Upside: +208.33%
Reiterated: Buy
Price Target: $55 → $56
Current: $26.14
Upside: +114.23%
Reiterated: Buy
Price Target: $55 → $56
Current: $26.72
Upside: +109.62%
Reiterated: Buy
Price Target: $29
Current: $16.12
Upside: +79.90%
Reiterated: Buy
Price Target: $34
Current: $2.14
Upside: +1,488.79%
Reiterated: Buy
Price Target: $36
Current: $12.85
Upside: +180.16%
Reiterated: Buy
Price Target: $56 → $78
Current: $64.63
Upside: +20.69%
Reiterated: Buy
Price Target: $13
Current: $2.53
Upside: +414.85%
Downgraded: Hold
Price Target: n/a
Current: $0.2843
Upside: -
Reiterated: Buy
Price Target: $20
Current: $8.37
Upside: +138.95%
Downgraded: Hold
Price Target: $3
Current: $0.025
Upside: +11,900.00%
Reiterated: Buy
Price Target: $27 → $21
Current: $2.70
Upside: +677.78%
Reiterated: Buy
Price Target: $7
Current: $0.919
Upside: +661.70%
Downgraded: Hold
Price Target: n/a
Current: $1.28
Upside: -
Initiated Coverage: Buy
Price Target: $16
Current: $0.6304
Upside: +2,438.07%
Rated: Buy
Price Target: $33 → $35
Current: $16.15
Upside: +116.72%
Reiterated: Buy
Price Target: $13
Current: $0.7538
Upside: +1,624.60%
Reiterated: Buy
Price Target: $7
Current: $4.91
Upside: +42.57%
Reiterated: Hold
Price Target: n/a
Current: $1.96
Upside: -
Reiterated: Buy
Price Target: $29
Current: $1.81
Upside: +1,502.21%
Reiterated: Hold
Price Target: n/a
Current: $3.07
Upside: -
Reiterated: Buy
Price Target: $8 → $11
Current: $0.6277
Upside: +1,652.43%
Downgraded: Sell
Price Target: n/a
Current: $19.07
Upside: -
Reiterated: Buy
Price Target: $8
Current: $0.9073
Upside: +781.74%
Reiterated: Hold
Price Target: n/a
Current: $6.33
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $15.54
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $2.96
Upside: n/a
Reiterated: Buy
Price Target: $110 → $20
Current: $0.4775
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $2.10
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $22.15
Upside: n/a
Reiterated: Buy
Price Target: $22
Current: $3.92
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $2.03
Upside: n/a
Reiterated: Sell
Price Target: n/a
Current: $1.64
Upside: n/a
Reiterated: Buy
Price Target: $10
Current: $0.7495
Upside: n/a